- Home
- Technology
- About Us
- Investors
- Publications
- News
- 2013
- 2012
- Interface Biologics Appoints Sandra Beach Lin to Board of Directors
- Medical device clears regulatory hurdle in the United States
- Interface Biologics announces Licensing Partner AngioDynamics has received FDA Clearance for BioFloTM PICC with EndexoTM Technology
- Many strengths and assets that Ontario's diverse life sciences sector has to offer
- AngioDynamics Earns FDA Clearance for First Vascular Access Product with BioFlo Technology to Reduce Catheter-Related Thrombus
- 2011
- Interface Biologics Announces $1 Million Investment By Ontario’s Investment Accelerator Fund – Life Sciences
- Interface Biologics announces Licensing Agreement with Navilyst Medical
- Fresenius Medical Care Executes Exclusive Interface Biologics License Agreement
- Interface Biologics Announces New VP Finance
- Interface Biologics Appoints Art Rosenthal to Chairman of its Board of Directors
- Interface Biologics Announces $7M Financing
- Interface Biologics - BASF Future Business Collaborate
- 2010
- 2009
- 2008
- 2007
- Partners
- Careers
Back
SITEMAP
- Home
- Technology
- About Us
- Investors
- Publications
- News
- 2013
- 2012
- Interface Biologics Appoints Sandra Beach Lin to Board of Directors
- Medical device clears regulatory hurdle in the United States
- Interface Biologics announces Licensing Partner AngioDynamics has received FDA Clearance for BioFloTM PICC with EndexoTM Technology
- Many strengths and assets that Ontario's diverse life sciences sector has to offer
- AngioDynamics Earns FDA Clearance for First Vascular Access Product with BioFlo Technology to Reduce Catheter-Related Thrombus
- 2011
- Interface Biologics Announces $1 Million Investment By Ontario’s Investment Accelerator Fund – Life Sciences
- Interface Biologics announces Licensing Agreement with Navilyst Medical
- Fresenius Medical Care Executes Exclusive Interface Biologics License Agreement
- Interface Biologics Announces New VP Finance
- Interface Biologics Appoints Art Rosenthal to Chairman of its Board of Directors
- Interface Biologics Announces $7M Financing
- Interface Biologics - BASF Future Business Collaborate
- 2010
- 2009
- 2008
- 2007
- Partners
- Careers
©Interface Biologics 2012. All rights reserved